Listed

Boston Scientific Corp

BSXNYSECIK 885725HealthcareFiscal year ends Dec 31

Reports and events: 396 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Boston Scientific Corp, Reports and events
FiledFormWhat it isAccession number
2024-05-0616:13 ET8-K5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0000885725-24-000048
2024-05-0116:05 ET10-QQuarterly reportPeriod 2024-03-310000885725-24-000046
2024-04-2406:34 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000885725-24-000040
2024-04-0407:19 ET8-K8.01 Other events0000885725-24-000037
2024-03-2017:06 ETDEF 14AProxy statementPeriod 2024-03-200000885725-24-000033
2024-02-2716:37 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits0000885725-24-000025
2024-02-2116:47 ET10-K/AAnnual report, amendedPeriod 2023-12-310000885725-24-000020
2024-02-2016:23 ET10-KAnnual reportPeriod 2023-12-310000885725-24-000017
2024-01-3116:32 ET8-K5.02 Departure or appointment of officers or directors0000885725-24-000014
2024-01-3106:32 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000885725-24-000011
2024-01-0817:17 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0000885725-24-000007
2024-01-0807:06 ET8-K7.01 Regulation FD disclosure0000885725-24-000003
2023-11-2216:04 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0000885725-23-000051
2023-11-0116:04 ET10-QQuarterly reportPeriod 2023-09-300000885725-23-000048
2023-10-2606:36 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000885725-23-000045
2023-08-0316:06 ET10-QQuarterly reportPeriod 2023-06-300000885725-23-000043
2023-07-2706:43 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000885725-23-000041
2023-06-2716:19 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000885725-23-000038
2023-06-0616:29 ET8-K8.01 Other events0000885725-23-000033
2023-05-0916:12 ET8-K5.07 Shareholder vote results0000885725-23-000028
2023-05-0416:07 ET10-QQuarterly reportPeriod 2023-03-310000885725-23-000026
2023-04-2606:34 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000885725-23-000024
2023-03-2216:17 ETDEF 14AProxy statementPeriod 2023-05-040000885725-23-000017
2023-03-0116:38 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000885725-23-000010
2023-02-2316:20 ET10-KAnnual reportPeriod 2022-12-310000885725-23-000008
2023-02-0106:34 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000885725-23-000004
2023-01-3116:54 ET8-K5.02 Departure or appointment of officers or directors0001104659-23-008661
2022-11-2116:32 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0000885725-22-000030
2022-11-0316:13 ET10-QQuarterly reportPeriod 2022-09-300000885725-22-000028
2022-10-2606:38 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000885725-22-000026
2022-08-0416:16 ET10-QQuarterly reportPeriod 2022-06-300000885725-22-000023
2022-07-2706:33 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000885725-22-000020
2022-05-0616:31 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001104659-22-057017
2022-05-0516:11 ET10-QQuarterly reportPeriod 2022-03-310000885725-22-000013
2022-04-2706:35 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000885725-22-000011
2022-04-0516:39 ET8-K5.02 Departure or appointment of officers or directors0000885725-22-000009
2022-03-2316:02 ETDEF 14AProxy statementPeriod 2022-05-050001104659-22-037008
2022-03-1716:31 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-22-035047
2022-03-0817:16 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-22-031615
2022-03-0206:03 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-22-028937
2022-02-2316:34 ET10-KAnnual reportPeriod 2021-12-310000885725-22-000006
2022-02-1516:19 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000885725-22-000004
2022-02-0206:35 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000885725-22-000002
2021-11-2316:13 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0000885725-21-000056
2021-11-0916:19 ET8-K8.01 Other events0000885725-21-000054
2021-11-0416:48 ET10-QQuarterly reportPeriod 2021-09-300000885725-21-000052
2021-10-2706:44 ET8-K2.02 Results of operations; 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits0000885725-21-000049
2021-10-0616:48 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000885725-21-000045
2021-09-2116:42 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000885725-21-000043
2021-09-0107:24 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000885725-21-000039

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 6, 2026, 17:38 ET. Listed shows no prices and gives no investment advice.